These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36017386)

  • 1. Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma.
    Wang D; Wang Z; Tao Y
    Biomed Res Int; 2022; 2022():8360481. PubMed ID: 36017386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles and prognostic values of BolA family members in ovarian cancer.
    Zhu M; Xiao S
    J Ovarian Res; 2021 Jun; 14(1):75. PubMed ID: 34078439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mRNA Expression of
    Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
    Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma.
    Li L; Song S; Fang X; Cao D
    BMC Med Genomics; 2021 Jan; 14(1):8. PubMed ID: 33407456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
    Yan J; Cao J; Chen Z
    BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma.
    Dai Q; Song F; Li X; Huang F; Zhao H
    BMC Cancer; 2022 Nov; 22(1):1121. PubMed ID: 36320006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma.
    Mei J; Wang H; Wang R; Pan J; Liu C; Xu J
    Biomed Res Int; 2020; 2020():5751939. PubMed ID: 32258128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
    Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
    Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.
    Ren X; Wang X; Yan Y; Chen X; Cai Y; Liang Q; Peng B; Xu Z; He Q; Kang F; Li J; Zhang W; Hong Q; Peng J; Xiao M
    Aging (Albany NY); 2022 Jan; 14(2):961-974. PubMed ID: 35077390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.
    Mei J; Yang X; Xia D; Zhou W; Gu D; Wang H; Liu C
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1384. PubMed ID: 32588988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
    Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
    Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.